Blood test study for Sézary syndrome diagnosis and treatment
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at a new blood test that might help doctors diagnose Sézary syndrome (a rare type of skin lymphoma) and see how well treatment is working. It also checks for leftover disease after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You need to have health insurance.
- You either have been diagnosed with Sézary syndrome, or you have widespread red, itchy skin (covering 80% or more of your body) that might be a type of skin lymphoma.
- A blood test must show a specific abnormal white blood cell (a T-cell clone) in both your blood and skin.
- You cannot have another cancer that is progressing or a severe mental health condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced blood tests (flow cytometry) to find cancer cells more accurately in people with cutaneous T-cell lymphoma. It could lead to better monitoring of your condition.
This study collects blood, urine, and possibly small tissue samples to learn more about cutaneous T-cell lymphoma (CTCL) and either eczema or atopic dermatitis. It may help researchers better understand these skin conditions and improve future treatments.
This trial looks at the results of different systemic (whole-body) treatments for cutaneous T-cell lymphoma (CTCL), a rare type of lymphoma that affects the skin. It aims to understand how well these therapies work and help guide future treatment choices.
This Phase 1 study tests whether the medicine bexarotene combined with radiotherapy can shrink or control mycosis fungoides, a skin lymphoma. It also looks at how safe the combination is and how the body handles the treatment.
This study tests an investigational pill called golidocitinib for two rare blood cancers: mycosis fungoides/Sézary syndrome (types of skin lymphoma) and T-cell large granular lymphocytic leukemia (a slow-growing leukemia). If you have one of these conditions and have already tried at least one treatment, you may be eligible to join.
This trial is testing new treatment plans based on the genetic type of your cutaneous T-cell lymphoma (CTCL). It's for people whose CTCL did not respond well to standard skin treatments.
Hear when a new Cutaneous T Cell Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.